Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

“Dr. Chen Chih-jung of Linkou Chang Gung Memorial Hospital stated in an interview on Thursday that hMPV is similar to ...

Flu, Respiratory Syncytial Virus (RSV) and COVID-19 cases are on the rise in East Texas mostly impacting children. The Texas ...

Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

ASC-60 is under clinical development by Sagimet Biosciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate ...

Approximately 40% of participants did not seroconvert or achieve a conservative neutralization threshold post-vaccination.

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV ...

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory ...

Former President Bill Clinton was discharged from the hospital after being treated for the flu. Meanwhile, here's the latest ...

Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract ...

Typically, flu activity starts to pick up around Halloween and peaks in February. This year, however, the virus got off to a ...

RSV activity remains high, with pediatric hospitalizations increasing across most of the country, the CDC said. Though ...